Alloy vs HealthHub
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
HealthHub
Best for Patients seeking a LegitScript-verifiable GLP-1 telehealth platform with maximum pharmacy-partner transparency (six named 503A-pattern compounders disclosed) and an oral dissolving tablet form factor for compounded semaglutide/tirzepatide, who are willing to sign up to see pricing.Side-by-Side Comparison
| Feature | Alloy | HealthHub |
|---|---|---|
| Overall Score | ✓7.4/10 | 6.4/10 |
| Starting Price | $80/mo | — |
| Editorial Rating | ✓3.7 ★ /5 | 3.2 ★ /5 |
| Features | 8 features | 8 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
HealthHub
Pros
- ✓LegitScript Certified with visible verification link (ID 46103909) — unique verifiable signal vs competitors that only display the badge
- ✓SIX named 503A-pattern pharmacy partners with city/state disclosure (AnazaoHealth Tampa FL, Tailor Made Nicholasville KY, Redrock Springville UT, Professional Arts Lafayette LA, Perfect RX Bartonville TX, Vios Livonia MI) — highest pharmacy-partner transparency in the WLR directory
- ✓Oral dissolving tablet (ODT) form factor for both semaglutide and tirzepatide (rare in DTC market)
- ✓'No subscriptions required' framing — lower commitment vs auto-renewal competitors
- ✓Cancellation policy linked publicly
Cons
- ✗Per-drug pricing NOT disclosed on the homepage — gated behind sign-up flow
- ✗Named medical director NOT disclosed (only 'board-certified providers' generic claim)
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed in footer or terms
- ✗Full states-served list NOT disclosed (only testimonial cities visible: Austin TX, Miami FL, Denver CO)
- ✗503A vs 503B designation NOT stated per pharmacy partner
- ✗FDA compounded-medication disclaimer NOT published verbatim on accessible pages
- ✗ODT form factor for GLP-1s has weaker comparative-efficacy evidence vs injectable (no STEP/SURMOUNT-equivalent oral compounded trials)
Our Verdict
Alloy edges out HealthHub with a higher overall score of 7.4/10 and is particularly strong for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory. HealthHub remains a solid alternative, especially if you're looking for Patients seeking a LegitScript-verifiable GLP-1 telehealth platform with maximum pharmacy-partner transparency (six named 503A-pattern compounders disclosed) and an oral dissolving tablet form factor for compounded semaglutide/tirzepatide, who are willing to sign up to see pricing..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.